FACULTY
Gina J. Ryan, PharmD, BCPS, CDE
Clinical Associate Professor
Director of Continuing Education
Department of Pharmacy Practice
Mercer University
College of Pharmacy and Health Sciences
Atlanta, GA

FINANCIAL DISCLOSURE
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Name of Faculty or Presenter	Reported Financial Relationship
Gina J. Ryan, PharmD	Clinical Investigator—Merck Receives grant/Research support—Solvay Speakers’ Bureau—Bristol-Myers Squibb, Eli Lilly

ACCREDITATION STATEMENTS
Pharmacy
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Program No.: 430-000-08-011-H01-P and 430-000-08-011-H01-T
Credits: 2.0 hours (0.20 ceu)

Published: July 1, 2008

Expires: July 31, 2010

Media: Monograph

Fee Information:
There is no fee for this educational program.

Estimated time to complete activity:
Estimated time to complete this program and posttest is 90 to 120 minutes.

Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

Direct educational content inquiries to:
CE Director (800) 331-9396

PROCEDURES
Please complete the posttest questions and program evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.

TARGET AUDIENCE
This accredited program is targeted to pharmacists and pharmacy technicians.

GOAL
To educate pharmacists on the importance of and approach to maintaining complete control of cholesterol levels.

EDUCATIONAL OBJECTIVES
After completing this program, participants will be able to:

1. Describe the importance of achieving recommended target levels of blood pressure, blood glucose levels, low-density lipoprotein cholesterol levels, high-density lipoprotein cholesterol levels, and very-low-density lipoprotein cholesterol levels;*
2. List the mechanism of action, effect on lipoprotein levels, and common adverse events of statins, fibric acid derivatives, niacin, bile acid sequestrants, ezetimibe, and omega-3 ethyl acids;*
3. List at least one investigational agent used in the treatment of lipid disorders;*
4. Describe the effects of combination therapy for lipid disorders;* and
5. List at least three ways that a pharmacist can improve the treatment of lipid disorders.

*Also applies to pharmacy technicians.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC and Merck & Co., Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer’s package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.